About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Kalam Dedicates New Cancer Drug Developed By Biocon

by Medindia Content Team on June 7, 2006 at 10:53 AM
Font : A-A+

Kalam Dedicates New Cancer Drug Developed By Biocon

President A P J Abdul Kalam today dedicated to the nation India's first indigenously developed drug for treating head and neck cancer.

Kalam congratulated Biocon scientists for developing the monoclonal antibody, BioMab EGFR (epidermal growth factor receptor), which company officials said works by binding to cancer cell-specific antigens and inducing an immunological response against the target cell.

Advertisement

Bangalore-based Biocon's chairperson Kiran Mazumdar-Shaw said the 'life-saving cancer drug' will hit the market in the next few months.

Company executives said though a large number of monoclonal antibodies have been launched in the country, they are beyond the reach of a majority of cancer patients because of their prohibitive cost.
Advertisement

They said Biocon's new drug will be effective in several types of cancer that express EGFR, including colo-rectal, pancreatic, metastatic breast, non small cell lung and brain cancers.

'BIOMab EGFR is indicated for use in combination with radiation therapy or chemotherapy in patients with positive expression of EGFR in squamous cell carcinoma of head and neck cancer,' the company said.

Kalam also inaugurated Biocon Park, the country's largest integrated bio-tech hub comprising an integrated cluster of laboratories and manufacturing facilities.

Built with a total investment of Rs 650 crore on a 90-acre plot, the park is the single largest capital investment made by Biocon in its 27-year history.

(Source:PTI News)
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Coffee May Help You Fight Endometrial Cancer
Fermented Skin Care
Television Binge-Watching May Boost the Risk of Deadly Blood Clots
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Oncology Drug Delivery Systems Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 
Recommended Reading
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...
Oncology Drug Delivery Systems
Drug delivery in oncology offers a localized, prolonged and protected drug interaction with the canc...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)